CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-15 | Tuck David Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +535,000 | 535,000 | ||
| 2018-05-15 | Dentzer James E COO & CFO | Grant or award · Employee stock option (right to buy) | +825,000 | 825,000 | ||
| 2018-05-15 | Fattaey Ali Ph.D. President & CEO | Grant or award · Employee stock option (right to buy) | +825,000 | 825,000 | ||
| 2018-01-22 | Martell Robert Director | Grant or award | +185,000 | 185,000 | ||
| 2018-01-22 | Kunkel Lori Anne Director | Grant or award | +185,000 | 185,000 | ||
| 2018-01-22 | Rubin Marc Director | Grant or award | +185,000 | 236,596 | ||
| 2018-01-22 | KAITIN KENNETH I Director | Grant or award | +185,000 | 214,607 | ||
| 2018-01-22 | GREENACRE MARTYN D Director | Grant or award | +185,000 | 222,945 | ||
| 2018-01-22 | Tuck David Chief Medical Officer | Grant or award | +133,750 | 169,424 | ||
| 2018-01-22 | Dentzer James E Chief Financial Officer | Grant or award | +206,250 | 212,011 | ||
| 2018-01-22 | Fattaey Ali Ph.D. President & CEO | Grant or award | +206,250 | 322,140 | ||
| 2017-11-16 | Rubin Marc Director | Purchase | +25,000 | $0.98 | $25K | 51,596 |
| 2017-11-15 | Fattaey Ali Ph.D. President & CEO | Purchase | +50,000 | $1.06 | $53K | 115,890 |
| 2017-05-31 | GREENACRE MARTYN D Director | Option exercise | +10,000 | $1.39 | $14K | 45,138 |
| 2017-05-31 | GREENACRE MARTYN D Director | Option exercise | +5,000 | $1.39 | $7K | 50,138 |
| 2017-05-31 | GREENACRE MARTYN D Director | Shares withheld for taxes | −12,193 | $1.71 | $21K | 37,945 |
| 2017-05-31 | GREENACRE MARTYN D Director | Option exercise · Non-qualified stock option (right to buy) | −10,000 | 0 | ||
| 2017-05-31 | GREENACRE MARTYN D Director | Option exercise · Non-qualified stock option (right to buy) | −5,000 | 0 | ||
| 2017-05-31 | KAITIN KENNETH I Director | Option exercise | +10,000 | $1.39 | $14K | 36,800 |
| 2017-05-31 | KAITIN KENNETH I Director | Option exercise | +5,000 | $1.39 | $7K | 41,800 |
Page 7 of 17 · 326 trades